• Skip to primary navigation
  • Skip to main content
Rebiotix Logo

Rebiotix

Powerful Therapy Delivered

  • Home
  • About
    • Senior Management
    • Stool Donor Program
    • Careers and Employment
  • Our Therapy
    • The Human Microbiome
    • Microbiota Restoration Therapy
    • Clostridioides difficile Infection
    • The Future of Microbiome-Based Therapeutics
  • Clinical Trials
    • RBX2660 Clinical Trials
    • RBX7455 Clinical Evaluation
    • Physician-sponsored Studies
    • Patient Resources
    • Expanded Access Policy
  • Science
    • Congress Publications
    • Manuscripts and Whitepapers
    • Related Evidence
  • Media
    • Latest Press Releases
    • Frequently Asked Questions
    • “Rebiotix” in the News
    • Conferences
    • Media Tools
    • Presentations & Videos
    • Contacts
  • Contact Us
  • Show Search
Hide Search
Home » About Rebiotix

About Rebiotix

Rebiotix is on the forefront of an exciting potential medical breakthrough

Harnessing the Power of the Human Microbiome

Rebiotix Inc., a Ferring Company, is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome.

The company is on the forefront of an exciting potential medical breakthrough with our MRT™ drug platform.  The MRT drug platform is leveraged to develop formulations consisting of live microbes, which are evaluated through our clinical program for the formulation’s ability to address challenging diseases.

Rebiotix looks to deliver on the promise of restoring the gut microbiota via standardized and stabilized investigational drugs that have been developed and tested under the auspices of a regulatory authority.

Video play time is 1:00 minute.

Key Milestones in Harnessing the Power of the Human Microbiome

  • Rebiotix was founded

    2011

  • Pre-Investigational New Drug (IND) meeting with FDA for RBX2660

    2012

  • FDA IND granted

    Fast Track designation granted

    PUNCH CD Phase 2 trial enrolled for RBX2660 to treat recurrent Clostridium difficile

    2013

  • FDA Orphan Drug designation granted

    Results of PUNCH CD announced

    PUNCH CD 2 (phase 2b) trial initiated

    Development of oral formulation, RBX7455, started

    2014

  • PUNCH CD 2 enrollment for RBX2660 completed

    FDA Breakthrough Therapy Status granted for RBX2660

    Oral formulation Drug Master File (DMF) filed with FDA

    2015

  • PUNCH CD 2 Randomized Double Blind Placebo Control Study results confirming Phase 2 data

    RBX7455 Non-Frozen Capsule feasibility study initiated

    2016

  • Rebiotix Reports Positive Top Line Data from Open-Label Phase 2 Trial of RBX2660 in Recurrent Clostridium difficile

    Phase 3 PUNCH CD3 initiated Q3 2017

    2017

  • Ferring acquires Rebiotix in April

    2018

  • Phase 3 Open Label PUNCH CD3-OLS Initiated Q2 2019

    2019

  • Phase 3 PUNCH CD3 Enrollment Completed

    Phase 3 PUNCH CD3 Positive Topline Results Announced

    2020

  • Phase 3 PUNCH CD3 Data presented at DDW 2021

    Phase 3 Open Label PUNCH CD3-OLS Interim Results presented at DDW 2021

    2021


Interested in Becoming a Stool Donor? Learn More

Rebiotix

  • Copyright © 2022 Rebiotix, Inc.
  • A Ferring Company
  • Privacy Policy
  • Terms of Use
  • Sitemap
  • Contact Us

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT